Dr. Laurence Cooper, CEO, Ziopharm Oncology points to earlier work in immunotherapy to explain the advances in cancer treatment that revolve around the genetic engineering of cells to control gene expression and manipulation of the DNA of cells such as T-cells to go after cancer cells. The next generation immunotherapy will allow cells and agents to adapt in real time to overcome resistance and empower T-cells to go after the cancer weak spots.
@ziopharm
#cancer #CancerResearch #Immunotherapy #oncology
Ziopharm.com
Download the transcript here
Empowered Patient Podcast